Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 63 | ECE2019 | Next issue

21st European Congress of Endocrinology

Lyon, France
18 May 2019 - 21 May 2019

Card image cap
18-21 May 2019, Lyon, France

Guided Posters

Benign Thyroid Disorders

Previous section
Obesity (1)
Table of contents
Next section
Adrenal and Neuroendocrine - Clinical

ea0063gp176 | Benign Thyroid Disorders

Do different initial doses of L-T4 within the range of 10–15 mcg/kg/die influence neurodevelopment during the first two years of life in children with congenital hypothyroidism?

ea0063gp177 | Benign Thyroid Disorders

Abstract unavailable

ea0063gp178 | Benign Thyroid Disorders

Cystic fibrosis as a novel cause of thyroxine (l-t4) malabsorption and increased requirement

ea0063gp179 | Benign Thyroid Disorders

Long-term cardiometabolic effects of maternal sub-optimal gestational thyroid function and relative treatment in the Controlled Antenatal Thyroid Screening (CATS) study II

ea0063gp180 | Benign Thyroid Disorders

Urinary concentration of iodotyrosines correlates with the severity of iodine deficiency in dehal1 knockout mice

ea0063gp181 | Benign Thyroid Disorders

Effect of anti-streptavidin interference when diagnosing thyroid disease using immunoassay analyses

ea0063gp182 | Benign Thyroid Disorders

Can hepcidin be a useful marker in the diagnosis and monitoring of de Quervain thyroiditis?

ea0063gp183 | Benign Thyroid Disorders

High-dose intravenous levothyroxine treatment as a successful, safe and clinically effective therapy option in severe hypothyroidism: a retrospective study

ea0063gp184 | Benign Thyroid Disorders

Effect of restoration of thyroid function on body composition, insulin resistance and visfatin concentrations in women with hypo- and hyperthyroidism

ea0063gp185 | Benign Thyroid Disorders

Thyroid-related adverse events in patients treated with Nivolumab and Pembrolizumab

ea0063gp186 | Benign Thyroid Disorders

Metformin reduces risk of benign nodular goiter in patients with type 2 diabetes mellitus

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more